Printer Friendly

/C O R R E C T I O N -- CANTAB PHARMACEUTICALS/

 In NY020, Cantab Pharmaceuticals Reports First Quarter Results, moved earlier today, we are advised by a representative of the company that in the Consolidated Statements of Income table, the table headings in the last two columns should read "First Quarter, March 31, 1993 and March 31, 1993," rather than "First Quarter, March 31, 1992 and March 31, 1992," as originally issued.
 -0- 5/27/93 C NY020
 /PRNewswire -- May 27/
 (CNTBY)


CO: Cantab Pharmaceuticals plc ST: IN: MTC SU: ERN

PS -- NY020A -- 3692 05/27/93 10:27 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 27, 1993
Words:89
Previous Article:COURT RULES AGAINST NEW ENGLAND ELECTRIC SYSTEM ON WASTE CLEANUP COSTS IN LYNN
Next Article:FLORIDA STATE BOARD OF ADMINISTRATION ADOPTS BROADER MONEY MANAGER EVALUATION SYSTEM
Topics:


Related Articles
CANTAB PHARMACEUTICALS REPORTS SECOND HALF YEAR AND YEAR END RESULTS
RESULTS OF PHASE I/II TRIAL ON LM-CD45 REPORTED AT BRITISH TRANSPLANT SOCIETY MEETING
CANTAB PHARMACEUTICALS SIGNS AGREEMENT WITH OXFORD UNIVERSITY AND REPORTS ON COLLABORATION WITH UNIVERSITY COLLEGE LONDON
SPI PHARMACEUTICALS ANNOUNCES SECOND QUARTER DIVIDEND
CANTAB PHARMACEUTICALS PLANS U.K. LISTING AND OFFERING
CANTAB REPORTS THE START OF A CLINICAL TRIAL CONDUCTED BY THE UNIVERSITY OF WALES COLLEGE OF MEDICINE FOR CERVICAL CANCER
CANTAB APPOINTS MICHAEL REDMOND TO BOARD OF DIRECTORS
CANTAB RECEIVES U.K. REGULATORY APPROVAL TO BEGIN CLINICAL TESTING OF DISC HSV
Cantab Pharmaceuticals Reports Second Quarter Results
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters